The crew faces an eight-month residency aboard the station, where they will conduct a series of scientific trials and technology demonstrations. Their mission is scheduled to conclude with a return to Earth in 2027. Central to the expedition is the study of human physiological adaptation in microgravity, specifically focusing on shifts in blood flow, vein structure, and blood composition.
Beyond physiological monitoring, Menon is tasked with testing a method for producing intravenous fluids from the station’s drinking water. This innovation serves as a critical proof-of-concept for sustaining future long-duration missions to the Moon and Mars. NASA confirmed that the team will also utilize augmented reality and artificial intelligence to perform advanced ultrasound procedures, refining medical support protocols for deep space exploration.





Comments (0)
No comments yet. Be the first!